Artículos Científicos

Home , Ty21a

Editor: NOEL GONZÁLEZ GOTERA Número 183 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 110415 -170415 Foto: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.

ARTÍCULOS CIENTÍFICOS

Publicaciones incluidas en PubMED durante el período comprendido entre el 11 y el 17 de abril de 2015. Con “vaccin*” en título: 154 artículos recuperados.

Vacunas meningococo (Neisseria meningitidis)

2. Immunogenicity and Safety of Meningococcal C Conjugate Vaccine in Children and Adolescents Infected and Uninfected with HIV in Rio de Janeiro, Brazil.

Frota AC, Milagres LG, Harrison LH, Ferreira B, Menna Barreto D, Pereira GS, Cruz AC, Pereira- Manfro W, de Oliveira RH, Abreu TF, Hofer CB.

Pediatr Infect Dis J. 2015 May;34(5):e113-e118.

PMID: 25876102

Related citations

Select item 25875985

18. Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme.

Tirani M, Meregaglia M, Melegaro A.

PLoS One. 2015 Apr 13;10(4):e0123383. doi: 10.1371/journal.pone.0123383. eCollection 2015.

PMID: 25874805

Related citations

Select item 25874777

19. Effectiveness of Meningococcal C Conjugate Vaccine in Salvador, Brazil: A Case-Control Study.

Cardoso CW, Ribeiro GS, Reis MG, Flannery B, Reis JN.

PLoS One. 2015 Apr 13;10(4):e0123734. doi: 10.1371/journal.pone.0123734. eCollection 2015.

PMID: 25874777

Related citations

Select item 25874726

83. Brazilian meningococcal C conjugate vaccine: Scaling up studies.

Bastos RC, de Souza IM, da Silva MN, Silva FP, Figueira ES, Leal ML, Jessouroun E, Junior JG, Medronho RA, da Silveira IA.

Vaccine. 2015 Apr 9. pii: S0264-410X(15)00427-2. doi: 10.1016/j.vaccine.2015.03.097. [Epub ahead of print]

PMID: 25865466

Related citations

Select item 25865249

138. The diversity of meningococcal carriage across the African meningitis belt and the impact of vaccination with a group A meningococcal conjugate vaccine.

African Meningococcal Carriage Consortium.

J Infect Dis. 2015 Apr 9. pii: jiv211. [Epub ahead of print]

PMID: 25858956

Related citations

Select item 25858860

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

16. Presence of mycobacterial L-forms in human blood: Challenge of BCG vaccination.

Markova N, Slavchev G, Michailova L.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25874947

Related citations

Select item 25874857

30. Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial.

Prentice S, Webb EL, Dockrell HM, Kaleebu P, Elliott AM, Cose S.

Trials. 2015 Apr 11;16(1):149. [Epub ahead of print]

PMID: 25872925

Related citations

Select item 25872647

113. A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable- syringe jet injector to conventional technique with needle and syringe.

Geldenhuys HD, Mearns H, Foster J, Saxon E, Kagina B, Saganic L, Jarrahian C, Tameris MD, Dintwe OB, Van Rooyen M, Luabeya KK, Hussey G, Scriba TJ, Hatherill M, Zehrung D.

Vaccine. 2015 Apr 7. pii: S0264-410X(15)00393-X. doi: 10.1016/j.vaccine.2015.03.074. [Epub ahead of print]

PMID: 25862299

Free Article

Related citations

Select item 25862196

121. Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.

Hesseling AC, Jaspan HB, Black GF, Nene N, Walzl G.

Int J Tuberc Lung Dis. 2015 Apr;19(4):454-62. doi: 10.5588/ijtld.14.0608.

PMID: 25860002

Related citations

Select item 25859680

Vacunas neumococo (Streptococcus pneumoniae)

25. The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program.

Ho YC, Lee PL, Wang YC, Chen SC, Chen KT.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25874476

Related citations

Select item 25874406

44. Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged 2 Years and Older: An Open-Label Study.

Cordonnier C, Ljungman P, Juergens C, Maertens J, Selleslag D, Sundaraiyer V, Giardina PC, Clarke K, Gruber WC, Scott DA, Schmoele-Thoma B; study group.

Clin Infect Dis. 2015 Apr 13. pii: civ287. [Epub ahead of print]

PMID: 25870329

Related citations

Select item 25870324

72. Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial.

Cordonnier C, Labopin M, Robin C, Ribaud P, Cabanne L, Chadelat C, Cesaro S, Ljungman P.

Bone Marrow Transplant. 2015 Apr 13. doi: 10.1038/bmt.2015.42. [Epub ahead of print]

PMID: 25867652

Related citations

Select item 25867018

120. Impact of the antipneumococcal conjugate vaccine on the occurrence of infectious respiratory diseases and hospitalization rates in children.

Abrão WM, Mello LM, Silva AS, Nunes AA.

Rev Soc Bras Med Trop. 2015 Jan-Feb;48(1):44-9. doi: 10.1590/0037-8682-0007-2015. Epub 2015 Jan 1.

PMID: 25860463 Free Article

Related citations

Select item 25860002

Vacunas Salmonella

31. Recombinant Salmonella-based CEACAM6 and 4-1BBL vaccine enhances T-cell immunity and inhibits the development of colorectal cancer in rats: In vivo effects of vaccine containing 4-1BBL and CEACAM6.

Jin C, Liu Y, Zhu J, Xia T, Zhang B, Fei Y, Ma B, Ye J, Chen W.

Oncol Rep. 2015 Apr 7. doi: 10.3892/or.2015.3901. [Epub ahead of print]

PMID: 25872647

Related citations

Select item 25872609

38. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans. 4

Wahid R, Fresnay S, Levine MM, Sztein MB.

Mucosal Immunol. 2015 Apr 15. doi: 10.1038/mi.2015.24. [Epub ahead of print]

PMID: 25872480

Related citations

Select item 25872013

45. Safety and immunogenicity of a Vi polysaccharide-Tetanus Toxoid conjugate vaccine (Typbar-TCVTM) in healthy infants, children and adults in typhoid endemic areas: a multi-center, two-cohort (open-label/double-blind, randomized, controlled), phase III study.

Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM.

Clin Infect Dis. 2015 Apr 13. pii: civ295. [Epub ahead of print]

PMID: 25870324

Related citations

Select item 25870140

88. Development of two salmonella-based oral vaccines against human respiratory syncytial virus.

Azizi Jalilian F, Yusoff K, Suhaimi S, Amini R, Sekawi Z, Jahanshiri F.

J Biol Regul Homeost Agents. 2015 Jan-Mar;29(1):7-18.

PMID: 25864737

Related citations

Select item 25864560

Vacuna tuberculosis (Mycobacterium tuberculosis)

37. Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.

Jeyanathan M, Thanthrige-Don N, Afkhami S, Lai R, Damjanovic D, Zganiacz A, Feng X, Yao XD, Rosenthal KL, Fe Medina M, Gauldie J, Ertl HC, Xing Z.

Mucosal Immunol. 2015 Apr 15. doi: 10.1038/mi.2015.29. [Epub ahead of print]

PMID: 25872483

Related citations

Select item 25872480

49. Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings: April 9, 2014, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.

Schrager L; Aerosol Vaccines for Tuberculosis Workshop Summary Group.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00379-5. doi: 10.1016/j.vaccine.2015.03.060. [Epub ahead of print]

PMID: 25869894

Related citations

Select item 25869893

54. Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference proceedings: November 7, 2014, National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA.

Schrager L; Vaccine Prevention of Sustained Mycobacterium tuberculosis Infection Summary Group.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00380-1. doi: 10.1016/j.vaccine.2015.03.061. [Epub ahead of print]

PMID: 25869889

Related citations

Select item 25869888

103. Aeras-sponsored meeting reports: Aerosol TB vaccines, whole mycobacteria cell TB vaccines, and prevention of sustained Mycobacterium tuberculosis infection.

Kaufmann SH.

Vaccine. 2015 Apr 8. pii: S0264-410X(15)00444-2. doi: 10.1016/j.vaccine.2015.04.001. [Epub ahead of print] No abstract available.

PMID: 25863114

Related citations

Select item 25862971

Vacuna tosferina (Bordetella pertussis)

87. Bordetella pertussis infection among international travellers: The need for a rigorous implementation of vaccine policies.

Gómez-Junyent J, Calvo-Cano A, Muñoz J, Gascón J.

Travel Med Infect Dis. 2015 Apr 2. pii: S1477-8939(15)00046-0. doi: 10.1016/j.tmaid.2015.03.011. [Epub ahead of print] No abstract available.

PMID: 25864792

Related citations

Select item 2586473

Preservantes (Tiomersal)

108. Thiomersal-containing vaccines - a review of the current state of knowledge.

Gołoś A, Lutyńska A.

Przegl Epidemiol. 2015;69(1):59-64. English, Polish.

PMID: 25862449 Free Article

Related citations

Select item 25862448

Vacunas, otras

1. Progress on adenovirus-vectored universal influenza vaccines.

Xiang K, Ying G, Yan Z, Shanshan Y, Lei Z, Hongjun L, Maosheng S.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25876176

Related citations

Select item 25876102 2.

Immunogenicity and Safety of Meningococcal C Conjugate Vaccine in Children and Adolescents Infected and Uninfected with HIV in Rio de Janeiro, Brazil.

Frota AC, Milagres LG, Harrison LH, Ferreira B, Menna Barreto D, Pereira GS, Cruz AC, Pereira-Manfro W, de Oliveira RH, Abreu TF, Hofer CB.

Pediatr Infect Dis J. 2015 May;34(5):e113-e118.

PMID: 25876102

Related citations

Select item 25875985 3.

One More Shot for the Road: A Review and Update of Vaccinations for Pediatric International Travelers.

Rebaza A, Lee PJ.

Pediatr Ann. 2015 Apr 1;44(4):e89-e96. doi: 10.3928/00904481-20150410-10.

PMID: 25875985

Related citations

Select item 25875983 4.

Vaccine-Preventable Outbreaks: Still with Us After All These Years.

Ruderfer D, Krilov LR.

Pediatr Ann. 2015 Apr 1;44(4):e76-e81. doi: 10.3928/00904481-20150410-08.

PMID: 25875983

Related citations

Select item 25875982 5.

Identifying and Addressing Vaccine Hesitancy.

Kestenbaum LA, Feemster KA.

Pediatr Ann. 2015 Apr 1;44(4):e71-e75. doi: 10.3928/00904481-20150410-07.

PMID: 25875982

Related citations

Select item 25875980 6.

Vaccines.

Krilov LR.

Pediatr Ann. 2015 Apr 1;44(4):150-151. doi: 10.3928/00904481-20150410-06. No abstract available.

PMID: 25875980

Related citations

Select item 25875868 7.

Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial. 8

Han SB, Rhim JW, Shin HJ, Lee SY, Kim HH, Kim JH, Lee KY, Ma SH, Park JS, Kim HM, Kim CS, Kim DH, Choi YY, Cha SH, Hong YJ, Kang JH.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25875868

Related citations

Select item 25875843 8.

Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial.

Munseri PJ, Kroidl A, Nilsson C, Joachim A, Geldmacher C, Mann P, Moshiro C, Aboud S, Lyamuya E, Maboko L, Missanga M, Kaluwa B, Mfinanga S, Podola L, Bauer A, Godoy- Ramirez K, Marovich M, Moss B, Hoelscher M, Gotch F, Stöhr W, Stout R, McCormack S, Wahren B, Mhalu F, Robb ML, Biberfeld G, Sandström E, Bakari M.

PLoS One. 2015 Apr 15;10(4):e0119629. doi: 10.1371/journal.pone.0119629. eCollection 2015.

PMID: 25875843

Related citations

Select item 25875802 9.

A literature review on the patients with autoimmune diseases following vaccination against infections.

Liang Y, Meng FY, Pan HF, Ye DQ.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25875802

Related citations

Select item 25875691 10.

Cell culture-based influenza vaccines: a necessary and indispensable investment for the future.

Hegde NR.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25875691

Related citations

Select item 25875534 11.

Human Vaccines and Immunotherapeutics: News.

Weiss A.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print] No abstract available.

PMID: 25875534

Related citations

Select item 25875257 12.

A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles.

Low N, Bavdekar A, Jeyaseelan L, Hirve S, Ramanathan K, Andrews NJ, Shaikh N, Jadi RS, Rajagopal A, Brown KE, Brown D, Fink JB, John O, Scott P, Riveros-Balta AX, Greco M, Dhere R, Kulkarni PS, Henao Restrepo AM.

N Engl J Med. 2015 Apr 16;372(16):1519-1529.

PMID: 25875257

Related citations

Select item 25875115 13.

Enhanced Mucosal Immune Responses Induced by a Combined Candidate Mucosal Vaccine Based on Hepatitis A Virus and Hepatitis E Virus Structural Proteins Linked to Tuftsin.

Gao Y, Su Q, Yi Y, Jia Z, Wang H, Lu X, Qiu F, Bi S.

PLoS One. 2015 Apr 13;10(4):e0123400. doi: 10.1371/journal.pone.0123400. eCollection 2015.

PMID: 25875115

Related citations

Select item 25875109 14.

A DNA Vaccine against Yellow Fever Virus: Development and Evaluation.

Maciel M Jr, Cruz FD, Cordeiro MT, da Motta MA, Cassemiro KM, Maia RC, de Figueiredo RC, Galler R, Freire MD, August JT, Marques ET, Dhalia R.

PLoS Negl Trop Dis. 2015 Apr 13;9(4):e0003693. doi: 10.1371/journal.pntd.0003693. eCollection 2015 Apr.

PMID: 25875109

Related citations

Select item 25874953 15.

Factors Associated to Vaccination against Influenza among Elderly in a Large Brazilian Metropolis.

Sato AP, Antunes JL, Moura RF, de Andrade FB, Duarte YA, Lebrão ML.

PLoS One. 2015 Apr 13;10(4):e0123840. doi: 10.1371/journal.pone.0123840. eCollection 2015.

PMID: 25874953

Related citations

Select item 25874947 16.

Presence of mycobacterial L-forms in human blood: Challenge of BCG vaccination.

Markova N, Slavchev G, Michailova L.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25874947

Related citations

Select item 25874857 17.

Ability of immunodiagnostic tests to differentiate between dogs naturally infected with Leishmania infantum and Leishmune^®-vaccinated dogs.

Ribeiro RA, Teixeira-Neto RG, Belo VS, Ferreira EC, Schallig HD, Silva ES.

Vet Res Commun. 2015 Feb 11. [Epub ahead of print]

PMID: 11

25874857

Related citations

Select item 25874805 18.

Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme.

Tirani M, Meregaglia M, Melegaro A.

PLoS One. 2015 Apr 13;10(4):e0123383. doi: 10.1371/journal.pone.0123383. eCollection 2015.

PMID: 25874805

Related citations

Select item 25874777 19.

Effectiveness of Meningococcal C Conjugate Vaccine in Salvador, Brazil: A Case-Control Study.

Cardoso CW, Ribeiro GS, Reis MG, Flannery B, Reis JN.

PLoS One. 2015 Apr 13;10(4):e0123734. doi: 10.1371/journal.pone.0123734. eCollection 2015.

PMID: 25874777

Related citations

Select item 25874726 20.

Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases.

Stein Zamir C, Schroeder H, Shoob H, Abramson N, Zentner G.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25874726

Related citations

Select item 25874696 21.

Serosurveillance of Vaccine Preventable Diseases and Hepatitis C in Healthcare Workers from Lao PDR.

Black AP, Vilivong K, Nouanthong P, Souvannaso C, Hübschen JM, Muller CP.

PLoS One. 2015 Apr 14;10(4):e0123647. doi: 10.1371/journal.pone.0123647. eCollection 2015.

PMID: 25874696

Related citations

Select item 25874632 22.

Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.

Tang J, Zhang N, Tao X, Zhao G, Guo Y, Tseng CT, Jiang S, Du L, Zhou Y.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25874632

Related citations

Select item 25874550 23.

Factors Associated with Seasonal Influenza Vaccination in Pregnant Women.

Henninger ML, Irving SA, Thompson M, Avalos LA, Ball SW, Shifflett P, Naleway AL.

J Womens Health (Larchmt). 2015 Apr 15. [Epub ahead of print]

PMID: 25874550

Related citations

Select item 25874544 24.

Determinants of Vaccine Immunogenicity in HIV-Infected Pregnant Women: Analysis of B and T Cell Responses to Pandemic H1N1 Monovalent Vaccine.

Weinberg A, Muresan P, Richardson KM, Fenton T, Dominguez T, Bloom A, Watts DH, Abzug MJ, Nachman SA, Levin MJ; P1086 team.

PLoS One. 2015 Apr 13;10(4):e0122431. doi: 10.1371/journal.pone.0122431. eCollection 2015.

PMID: 25874544

Related citations

Select item 25874476 25.

The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program.

Ho YC, Lee PL, Wang YC, Chen SC, Chen KT.

Hum Vaccin Immunother. 2015 Apr 15:0. [Epub ahead of print]

PMID: 25874476

Related citations

Select item 25874406 26.

Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees.

Choi I, Chung AW, Suscovich TJ, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, O'Connell RJ, Francis D, Robb ML, Michael NL, Kim JH, Alter G, Ackerman ME, Bailey-Kellogg C.

PLoS Comput Biol. 2015 Apr 13;11(4):e1004185. doi: 10.1371/journal.pcbi.1004185. eCollection 2015 Apr.

PMID: 25874406

Related citations

Select item 25874208 27.

Biological Effects of Listeriolysin O: Implications for Vaccination.

Hernández-Flores KG, Vivanco-Cid H.

Biomed Res Int. 2015;2015:360741. Epub 2015 Mar 22. Review.

PMID: 25874208

Related citations

Select item 25872991 28.

[Contribution of the detection of IgA antibodies to the laboratory diagnosis of mumps in the population with a high vaccination coverage].

Limberková R, Smíšková D, Havlíčková M, Herrmannová K, Lexová P, Malý M.

Epidemiol Mikrobiol Imunol. 2015 Winter;64(1):16-9. Czech.

PMID: 25872991

Related citations

Select item 25872936 29.

Evaluation of tumour vaccine immunotherapy for the treatment of advanced non-small cell lung cancer: a systematic meta-analysis.

Wang M, Cao JX, Liu YS, Xu BL, Li D, Zhang XY, Li JL, Liu JL, Wang HB, Wang ZX.

BMJ Open. 2015 Apr 14;5(4):e006321. doi: 10.1136/bmjopen-2014-006321.

PMID: 25872936

Related citations

Select item 25872925 30.

Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial.

Prentice S, Webb EL, Dockrell HM, Kaleebu P, Elliott AM, Cose S.

Trials. 2015 Apr 11;16(1):149. [Epub ahead of print]

PMID: 25872925

Related citations

Select item 25872647 31.

Recombinant Salmonella-based CEACAM6 and 4-1BBL vaccine enhances T-cell immunity and inhibits the development of colorectal cancer in rats: In vivo effects of vaccine containing 4-1BBL and CEACAM6.

Jin C, Liu Y, Zhu J, Xia T, Zhang B, Fei Y, Ma B, Ye J, Chen W.

Oncol Rep. 2015 Apr 7. doi: 10.3892/or.2015.3901. [Epub ahead of print]

PMID: 15

25872647

Related citations

Select item 25872609 32.

The impact of epidemics of vaccine-preventable disease on vaccine uptake: lessons from the 2011-2012 US pertussis epidemic.

Wolf ER, Rowhani-Rahbar A, Opel DJ.

Expert Rev Vaccines. 2015 Apr 15:1-11. [Epub ahead of print]

PMID: 25872609

Related citations

Select item 25872565 33.

Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain.

Pérez-Vilar S, Díez-Domingo J, López-Lacort M, Martínez-Úbeda S, Martinez-Beneito MA.

BMC Infect Dis. 2015 Feb 25;15(1):92. doi: 10.1186/s12879-015-0811-5.

PMID: 25872565

Related citations

Select item 25872557 34.

Influenza vaccination in pediatric age.

Esposito S, Principi N.

Expert Rev Vaccines. 2015 Apr 15:1-3. [Epub ahead of print]

PMID: 25872557

Related citations

Select item 25872549 35.

Suspected side effects to the quadrivalent human papilloma vaccine.

Brinth L, Theibel AC, Pors K, Mehlsen J.

Dan Med J. 2015 Apr;62(4). pii: A5064.

PMID: 25872549

Related citations

Select item 25872531 36.

The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial.

Low JG, Wijaya L, Li GK, Lim EY, Shum AK, Cheung YB, Ooi EE.

Trials. 2015 Apr 10;16(1):147. [Epub ahead of print]

PMID: 25872531

Related citations

Select item 25872483 37.

Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.

Jeyanathan M, Thanthrige-Don N, Afkhami S, Lai R, Damjanovic D, Zganiacz A, Feng X, Yao XD, Rosenthal KL, Fe Medina M, Gauldie J, Ertl HC, Xing Z.

Mucosal Immunol. 2015 Apr 15. doi: 10.1038/mi.2015.29. [Epub ahead of print]

PMID: 25872483

Related citations

Select item 25872480 38.

Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.

Wahid R, Fresnay S, Levine MM, Sztein MB.

Mucosal Immunol. 2015 Apr 15. doi: 10.1038/mi.2015.24. [Epub ahead of print]

PMID: 25872480

Related citations

Select item 25872013 39.

Let It "B"? The Role of Hepatitis B Universal Vaccination among Italian Problematic Drug Users.

Lugoboni F, Pavarin RM, Resentera C, Gambini D.

Int J Environ Res Public Health. 2015 Apr 13;12(4):3979-92. doi: 10.3390/ijerph120403979.

PMID: 25872013 Free Article

Related citations

Select item 25871827 40.

Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine.

Riede O, Seifert K, Oswald D, Endmann A, Hock C, Winkler A, Salguero FJ, Schroff M, Croft SL, Juhls C.

Gene Ther. 2015 Apr 14. doi: 10.1038/gt.2015.35. [Epub ahead of print]

PMID: 25871827

Related citations

Select item 25871452 41.

Dual response to human papilloma virus vaccine in an immunodeficiency disorder: resolution of plantar warts and persistence of condylomas.

Moscato GM, Di Matteo G, Ciotti M, Di Bonito P, Andreoni M, Moschese V.

J Eur Acad Dermatol Venereol. 2015 Apr 13. doi: 10.1111/jdv.13133. [Epub ahead of print] No abstract available.

PMID: 25871452

Related citations

Select item 25870859 42.

Changes in knowledge of cervical cancer following introduction of human papillomavirus vaccine among women at high risk for cervical cancer.

Massad LS, Evans CT, Weber KM, D'Souza G, Hessol NA, Wright RL, Colie C, Strickler HD, Wilson TE.

Gynecol Oncol Rep. 2015 Apr 1;12:37-40.

PMID: 25870859

Related citations

Select item 25870600 43.

Inoculation site from a cutaneous melanoma patient treated with an allogeneic therapeutic vaccine: a case report.

Aris M, Bravo AI, Barrio MM, Mordoh J.

Front Immunol. 2015 Mar 30;6:144. doi: 10.3389/fimmu.2015.00144. eCollection 2015.

PMID: 25870600 Free Article

Related citations

Select item 25870329 44.

Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged 2 Years and Older: An Open-Label Study.

Cordonnier C, Ljungman P, Juergens C, Maertens J, Selleslag D, Sundaraiyer V, Giardina PC, Clarke K, Gruber WC, Scott DA, Schmoele-Thoma B; study group.

Clin Infect Dis. 2015 Apr 13. pii: civ287. [Epub ahead of print]

PMID: 25870329

Related citations

Select item 25870324 45.

Safety and immunogenicity of a Vi polysaccharide-Tetanus Toxoid conjugate vaccine (Typbar-TCVTM) in healthy infants, children and adults in typhoid endemic areas: a multi-center, two-cohort (open-label/double-blind, randomized, controlled), phase III study. 19

Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM.

Clin Infect Dis. 2015 Apr 13. pii: civ295. [Epub ahead of print]

PMID: 25870324

Related citations

Select item 25870140 46.

Live virus vaccines in transplantation: friend or foe?

Verolet CM, Posfay-Barbe KM.

Curr Infect Dis Rep. 2015 Apr;17(4):472. doi: 10.1007/s11908-015-0472-y.

PMID: 25870140

Related citations

Select item 25869965 47.

Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens.

Fan Y, Sahdev P, Ochyl LJ, Akerberg J, Moon JJ.

J Control Release. 2015 Apr 11. pii: S0168-3659(15)00228-X. doi: 10.1016/j.jconrel.2015.04.010. [Epub ahead of print]

PMID: 25869965

Related citations

Select item 25869895 48.

Actions improving HPV vaccination uptake - Results from a national survey in Italy.

Giambi C, Del Manso M, D'Ancona F, De Mei B, Giovannelli I, Cattaneo C, Possenti V, Declich S; Local representatives for VALORE.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00460-0. doi: 10.1016/j.vaccine.2015.04.007. [Epub ahead of print]

PMID: 25869895

Related citations 20

Select item 25869894 49.

Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings: April 9, 2014, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.

Schrager L; Aerosol Vaccines for Tuberculosis Workshop Summary Group.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00379-5. doi: 10.1016/j.vaccine.2015.03.060. [Epub ahead of print]

PMID: 25869894

Related citations

Select item 25869893 50.

Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine.

Goss MA, Lievano F, Buchanan KM, Seminack MM, Cunningham ML, Dana A.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00467-3. doi: 10.1016/j.vaccine.2015.04.014. [Epub ahead of print]

PMID: 25869893

Related citations

Select item 25869892 51.

Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the last four seasons 2010-2014.

Jiménez-Jorge S, Pozo F, Larrauri A, de Mateo S, Delgado- Sanz C, Casas I, García- Cenoz M, Castilla J, Rodríguez C, Vega T, Quiñones C, Martínez E, Vanrell JM, Giménez J, Castrillejo D, Altzíbar JM, González-Carril F, Ramos JM, Serrano MC, Martínez A, Torner N, Pérez E, Gallardo V; cycEVA Study Team.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00359-X. doi: 10.1016/j.vaccine.2015.03.051. [Epub ahead of print]

PMID: 25869892

Related citations

Select item 25869891 52.

Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.

Örtqvist Å, Bennet R, Hamrin J, Rinder MR, Lindblad H, Öhd JN, Eriksson M.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00464-8. doi: 10.1016/j.vaccine.2015.04.011. [Epub ahead of print]

PMID: 25869891

Related citations

Select item 25869890 53.

Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate.

Fontana D, Kratje R, Etcheverrigaray M, Prieto C.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00418-1. doi: 10.1016/j.vaccine.2015.03.088. [Epub ahead of print]

PMID: 25869890

Related citations

Select item 25869889 54.

Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference proceedings: November 7, 2014, National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA.

Schrager L; Vaccine Prevention of Sustained Mycobacterium tuberculosis Infection Summary Group.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00380-1. doi: 10.1016/j.vaccine.2015.03.061. [Epub ahead of print]

PMID: 25869889

Related citations

Select item 25869888 55.

Internet activity as a proxy for vaccination compliance.

Barak-Corren Y, Reis BY.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00439-9. doi: 10.1016/j.vaccine.2015.03.100. [Epub ahead of print]

PMID: 25869888

Related citations

Select item 25869886 56.

Nudges or mandates? The ethics of mandatory flu vaccination.

Dubov A, Phung C.

Vaccine. 2015 Apr 10. pii: S0264-410X(15)00356-4. doi: 10.1016/j.vaccine.2015.03.048. [Epub ahead of print] Review.

PMID: 25869886

Related citations

Select item 25869880 57.

Engineering human rhinovirus serotype-A1 as a vaccine vector.

Tomusange K, Yu W, Suhrbier A, Wijesundara D, Grubor-Bauk B, Gowans EJ.

Virus Res. 2015 Apr 10. pii: S0168-1702(15)00136-7. doi: 10.1016/j.virusres.2015.04.002. [Epub ahead of print]

PMID: 25869880

Related citations

Select item 25869659 58.

Vaccinia Virus Infection Requires Maturation of Macropinosomes.

Rizopoulos Z, Balistreri G, Kilcher S, Martin CK, Syedbasha M, Helenius A, Mercer J.

Traffic. 2015 Apr 14. doi: 10.1111/tra.12290. [Epub ahead of print]

PMID: 25869659

Related citations

Select item 25869538 59. 23

Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates.

Jones S, Grignard L, Nebie I, Chilongola J, Dodoo D, Sauerwein R, Theisen M, Roeffen W, Singh SK, Singh RK, Singh S, Kyei-Baafour E, Tetteh K, Drakeley C, Bousema T.

J Infect. 2015 Apr 10. pii: S0163-4453(15)00091-2. doi: 10.1016/j.jinf.2015.03.007. [Epub ahead of print]

PMID: 25869538

Related citations

Select item 25869378 60.

Childhood Vaccination Coverage Rates Among Military Dependents in the United States.

Dunn AC, Black CL, Arnold J, Brodine S, Waalen J, Binkin N.

Pediatrics. 2015 Apr 13. pii: peds.2014-2101. [Epub ahead of print]

PMID: 25869378

Related citations

Select item 25869226 61.

Superior immunologic and therapeutic efficacy of a xenogeneic genetic cancer vaccine targeting carcinoembryonic human antigen.

Aurisicchio L, Roscilli G, Marra E, Luberto L, Mancini R, La Monica N, Ciliberto G.

Hum Gene Ther. 2015 Apr 14. [Epub ahead of print]

PMID: 25869226

Related citations

Select item 25868754 62.

Active Immunization with DNA Vaccine Reduced Cerebral Inflammation and Improved Cognitive Ability in APP/PS1 Transgenic Mice by In Vivo Electroporation.

Xing XN, Sha S, Chen XH, Guo WS, Guo R, Jiang TZ, Cao YP.

Neurochem Res. 2015 Apr 14. [Epub ahead of print]

PMID: 25868754

Related citations

Select item 25868727 63.

Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters.

Saupe F, Huijbers EJ, Hein T, Femel J, Cedervall J, Olsson AK, Hellman L.

FASEB J. 2015 Apr 13. pii: fj.15-271502. [Epub ahead of print]

PMID: 25868727

Related citations

Select item 25868476 64.

Best Vaccination Practice and Medically Attended Injection Site Events Following Deltoid Intramuscular Injection.

Cook IF.

Hum Vaccin Immunother. 2015 Apr 14:0. [Epub ahead of print]

PMID: 25868476

Related citations

Select item 25868280 65.

[Construction of a full-length cDNA clone of a live attenuated vaccine strain against Japanese encephalitis virus and preliminary study of expressing exogenous gene].

Hu B, Yang S, Fang ZZ.

Bing Du Xue Bao. 2014 Nov;30(6):652-60. Chinese.

PMID: 25868280

Related citations

Select item 25868279 66.

[A novel immunization strategy to induce strong humoral responses against HIV-1 using combined DNA, recombinant vaccinia virus and protein vaccines]. 25

Liu C, Wang SH, Ren L, Hao YL, Zhang QC, Liu Y.

Bing Du Xue Bao. 2014 Nov;30(6):645-51. Chinese.

PMID: 25868279

Related citations

Select item 25868137 67.

Seroprevalence and Seroincidence of Herpes Simplex Virus (2006-2010), Syphilis (2006-2010), and Vaccine-Preventable Human Papillomavirus Subtypes (2000-2010) Among US Military Personnel.

Masel J, Deiss RG, Wang X, Sanchez JL, Ganesan A, Macalino GE, Gaydos JC, Kortepeter MG, Agan BK.

Sex Transm Dis. 2015 May;42(5):253-8. doi: 10.1097/OLQ.0000000000000277.

PMID: 25868137

Related citations

Select item 25868124 68.

Characterization of in vitro antifungal activities of small and American cranberry (Vaccinium oxycoccos L. and V. macrocarpon Aiton) and lingonberry (Vaccinium vitis- idaea L.) concentrates in sugar reduced fruit spreads.

Ermis E, Hertel C, Schneider C, Carle R, Stintzing F, Schmidt H.

Int J Food Microbiol. 2015 Mar 27;204:111-117. doi: 10.1016/j.ijfoodmicro.2015.03.017. [Epub ahead of print]

PMID: 25868124

Related citations

Select item 25868116 69.

Synthesis of a 1,3 β-glucan hexasaccharide designed to target vaccines to the dendritic cell receptor, Dectin-1.

Elsaidi HR, Paszkiewicz E, Bundle DR.

Carbohydr Res. 2015 Mar 14;408:96-106. doi: 10.1016/j.carres.2015.03.007. [Epub ahead of print]

PMID: 25868116

Related citations

Select item 25867857 70.

Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticles.

Kokate RA, Thamake SI, Chaudhary P, Mott B, Raut S, Vishwanatha JK, Jones HP.

Nanomedicine (Lond). 2015 Mar;10(6):915-29. doi: 10.2217/nnm.14.144.

PMID: 25867857

Related citations

Select item 25867731 71.

Vaccination, infection, and the risk for multiple sclerosis.

Krone B, Grange JM.

JAMA Neurol. 2015 Apr 1;72(4):480. doi: 10.1001/jamaneurol.2014.4708. No abstract available.

PMID: 25867731

Related citations

Select item 25867652 72.

Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial.

Cordonnier C, Labopin M, Robin C, Ribaud P, Cabanne L, Chadelat C, Cesaro S, Ljungman P.

Bone Marrow Transplant. 2015 Apr 13. doi: 10.1038/bmt.2015.42. [Epub ahead of print]

PMID: 25867652

Related citations

Select item 25867018 73.

A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.

Graham DM, Isaranuwatchai W, Habbous S, de Oliveira C, Liu G, Siu LL, Hoch JS.

Cancer. 2015 Apr 13. doi: 10.1002/cncr.29111. [Epub ahead of print]

PMID: 25867018

Related citations

Select item 25866403 74.

Immunoreactivity and morphological changes of bursal follicles in chickens infected with vaccine or wild-type strains of the infectious bursal disease virus.

Aihara N, Horiuchi N, Hikichi N, Ochiai M, Hosoda Y, Ishikawa Y, Shimazaki Y, Oishi K.

J Vet Med Sci. 2015 Apr 10. [Epub ahead of print]

PMID: 25866403 Free Article

Related citations

Select item 25865968 75.

The narrow road to the indigenous rotavirus vaccine.

Das BK.

Indian J Med Microbiol. 2015 Apr-Jun;33(2):203-4. doi: 10.4103/0255-0857.154847. No abstract available.

PMID: 25865968 Free Article

Related citations

Select item 25865807 76.

Erratum to: Lactic acid bacteria-20 years exploring their potential as live vectors for mucosal vaccination.

Wyszyńska A, Kobierecka P, Bardowski J, Jagusztyn-Krynicka EK.

Appl Microbiol Biotechnol. 2015 Apr 14. [Epub ahead of print] No abstract available.

PMID: 25865807

Related citations

Select item 25865472 77.

Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.

Prescott J, DeBuysscher BL, Feldmann F, Gardner DJ, Haddock E, Martellaro C, Scott D, Feldmann H.

Vaccine. 2015 Apr 9. pii: S0264-410X(15)00419-3. doi: 10.1016/j.vaccine.2015.03.089. [Epub ahead of print]

PMID: 25865472

Related citations

Select item 25865471 78.

Subpopulations in aMPV vaccines are unlikely to be the only cause of reversion to virulence.

Franzo G, Naylor CJ, Drigo M, Croville G, Ducatez MF, Catelli E, Laconi A, Cecchinato M.

Vaccine. 2015 Apr 9. pii: S0264-410X(15)00422-3. doi: 10.1016/j.vaccine.2015.03.092. [Epub ahead of print]

PMID: 25865471

Related citations

Select item 25865470 79.

Adjuvant activity of fish type I interferon shown in a virus DNA vaccination model.

Chang CJ, Sun B, Robertsen B.

Vaccine. 2015 Apr 9. pii: S0264-410X(15)00423-5. doi: 10.1016/j.vaccine.2015.03.093. [Epub ahead of print]

PMID: 25865470 Free Article

Related citations

Select item 25865469 80.

Construction of a triple gene-deleted Chinese Pseudorabies virus variant and its efficacy study as a vaccine candidate on suckling piglets.

Zhang C, Guo L, Jia X, Wang T, Wang J, Sun Z, Wang L, Li X, Tan F, Tian K.

Vaccine. 2015 Apr 9. pii: S0264-410X(15)00424-7. doi: 10.1016/j.vaccine.2015.03.094. [Epub ahead of print]

PMID: 25865469

Related citations

Select item 25865468 81.

First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity.

Schijns VE, Pretto C, Devillers L, Pierre D, Hofman FM, Chen TC, Mespouille P, Hantos P, Glorieux P, Bota DA, Stathopoulos A.

Vaccine. 2015 Apr 9. pii: S0264-410X(15)00425-9. doi: 10.1016/j.vaccine.2015.03.095. [Epub ahead of print]

PMID: 25865468 Free Article

Related citations

Select item 25865467 82.

Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.

Mvundura M, Lorenson K, Chweya A, Kigadye R, Bartholomew K, Makame M, Lennon P, Mwangi S, Kirika L, Kamau P, Otieno A, Murunga P, Omurwa T, Dafrossa L, Kristensen D.

Vaccine. 2015 Apr 9. pii: S0264-410X(15)00414-4. doi: 10.1016/j.vaccine.2015.03.084. [Epub ahead of print]

PMID: 25865467

Related citations

Select item 25865466 83. 30

Brazilian meningococcal C conjugate vaccine: Scaling up studies.

Bastos RC, de Souza IM, da Silva MN, Silva FP, Figueira ES, Leal ML, Jessouroun E, Junior JG, Medronho RA, da Silveira IA.

Vaccine. 2015 Apr 9. pii: S0264-410X(15)00427-2. doi: 10.1016/j.vaccine.2015.03.097. [Epub ahead of print]

PMID: 25865466

Related citations

Select item 25865249 84.

Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014.

McAnerney JM, Treurnicht F, Walaza S, Cohen AL, Tempia S, Mtshali S, Buys A, Blumberg L, Cohen C.

Influenza Other Respir Viruses. 2015 Apr 11. doi: 10.1111/irv.12314. [Epub ahead of print]

PMID: 25865249

Related citations

Select item 25865003 85.

Adaptive immunity & vaccination.

[No authors listed]

J Invest Dermatol. 2015 May;135 Suppl 1:S1-8. doi: 10.1038/jid.2015.66. No abstract available.

PMID: 25865003 Free Article

Related citations

Select item 25864917 86.

Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agent.

Lin X, Chen S, Xue X, Lu L, Zhu S, Li W, Chen X, Zhong X, Jiang P, Sename TS, Zheng Y, Zhang L.

Cell Mol Immunol. 2015 Apr 13. doi: 10.1038/cmi.2015.29. [Epub ahead of print]

PMID: 25864917

Related citations

Select item 25864792 87.

Bordetella pertussis infection among international travellers: The need for a rigorous implementation of vaccine policies.

Gómez-Junyent J, Calvo-Cano A, Muñoz J, Gascón J.

Travel Med Infect Dis. 2015 Apr 2. pii: S1477-8939(15)00046-0. doi: 10.1016/j.tmaid.2015.03.011. [Epub ahead of print] No abstract available.

PMID: 25864792

Related citations

Select item 25864737 88.

Development of two salmonella-based oral vaccines against human respiratory syncytial virus.

Azizi Jalilian F, Yusoff K, Suhaimi S, Amini R, Sekawi Z, Jahanshiri F.

J Biol Regul Homeost Agents. 2015 Jan-Mar;29(1):7-18.

PMID: 25864737

Related citations

Select item 25864560 89.

Human vaccines and immunotherapeutics: news.

[No authors listed]

Hum Vaccin Immunother. 2014 Dec 2;10(12):3427-9. doi: 10.1080/21645515.2014.1003502. No abstract available.

PMID: 25864560

Related citations

Select item 25864502 90.

Middle East respiratory syndrome: obstacles and prospects for vaccine development.

Papaneri AB, Johnson RF, Wada J, Bollinger L, Jahrling PB, Kuhn JH.

Expert Rev Vaccines. 2015 Apr 11:1-14. [Epub ahead of print]

PMID: 25864502

Related citations

Select item 25864428 91.

Live attenuated influenza vaccine tetravalent: a clinical review.

Bandell AR, Simões EA.

Expert Rev Vaccines. 2015 Apr 11:1-11. [Epub ahead of print]

PMID: 25864428

Related citations

Select item 25864107 92.

Live attenuated vaccines: Historical successes and current challenges.

Minor PD.

Virology. 2015 Apr 8. pii: S0042-6822(15)00172-5. doi: 10.1016/j.virol.2015.03.032. [Epub ahead of print] Review.

PMID: 25864107 Free Article

Related citations

Select item 25863968 93.

Protective immune responses in ducklings induced by a suicidal DNA vaccine of the sigma C gene of novel duck reovirus.

Zhu Y, Li C, Bi Z, Chen Z, Meng C, Wang GJ, Ding C, Liu G.

Vet Immunol Immunopathol. 2015 Mar 6. pii: S0165-2427(15)00056-2. doi: 10.1016/j.vetimm.2015.03.001. [Epub ahead of print] 33

PMID: 25863968

Related citations

Select item 25863879 94.

The vaccinia virus E6 protein influences virion protein localization during virus assembly.

Condit RC, Moussatche N.

Virology. 2015 Apr 9;482:147-156. doi: 10.1016/j.virol.2015.02.056. [Epub ahead of print]

PMID: 25863879

Related citations

Select item 25863557 95.

Understanding How Different Recruitment Strategies Impact Parent Engagement With an iPad-Based Intervention to Provide Personalized Information About Adolescent Vaccines.

Dempsey AF, Maertens J, Beaty BL, O'Leary ST.

J Adolesc Health. 2015 May;56(5 Suppl):S7-S13. doi: 10.1016/j.jadohealth.2014.11.022.

PMID: 25863557

Related citations

Select item 25863556 96.

Human papillomavirus vaccines: an ounce of prevention is worth pounds of cures.

Gellin B.

J Adolesc Health. 2015 May;56(5 Suppl):S5-6. doi: 10.1016/j.jadohealth.2015.02.001. No abstract available.

PMID: 25863556

Related citations

Select item 25863554 97.

Increasing human papillomavirus vaccine initiation among publicly insured Florida adolescents.

Staras SA, Vadaparampil ST, Livingston MD, Thompson LA, Sanders AH, Shenkman EA.

J Adolesc Health. 2015 May;56(5 Suppl):S40-6. doi: 10.1016/j.jadohealth.2014.11.024.

PMID: 25863554

Related citations

Select item 25863552 98.

Interventions to improve adolescent vaccination coverage.

Stokley S.

J Adolesc Health. 2015 May;56(5 Suppl):S3-4. doi: 10.1016/j.jadohealth.2015.02.004. No abstract available.

PMID: 25863552

Related citations

Select item 25863548 99.

Keen on teen vaccines: improvement of adolescent vaccine coverage in rural north Carolina.

Chung RJ, Walter EB, Kemper AR, Dayton A.

J Adolesc Health. 2015 May;56(5 Suppl):S14-6. doi: 10.1016/j.jadohealth.2014.10.272.

PMID: 25863548

Related citations

Select item 25863547 100.

Innovative clinical and public health strategies to promote adolescent vaccination.

Kahn JA, Rickert VI.

J Adolesc Health. 2015 May;56(5 Suppl):S1-2. doi: 10.1016/j.jadohealth.2015.02.002. No abstract available.

PMID: 25863547

Related citations

Select item 25863196 101.

Nanoparticles as synthetic vaccines.

Smith JD, Morton LD, Ulery BD.

Curr Opin Biotechnol. 2015 Apr 6;34:217-224. doi: 10.1016/j.copbio.2015.03.014. [Epub ahead of print] Review.

PMID: 25863196

Related citations

Select item 25863115 102.

A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.

Zhang H, Qian P, Peng B, Shi L, Chen H, Li X.

Vaccine. 2015 Apr 8. pii: S0264-410X(15)00420-X. doi: 10.1016/j.vaccine.2015.03.090. [Epub ahead of print]

PMID: 25863115

Related citations

Select item 25863114 103.

Aeras-sponsored meeting reports: Aerosol TB vaccines, whole mycobacteria cell TB vaccines, and prevention of sustained Mycobacterium tuberculosis infection.

Kaufmann SH.

Vaccine. 2015 Apr 8. pii: S0264-410X(15)00444-2. doi: 10.1016/j.vaccine.2015.04.001. [Epub ahead of print] No abstract available.

PMID: 25863114

Related citations

Select item 25862971 104.

Effect of a new recombinant Aeromonas hydrophila vaccine on the grass carp intestinal microbiota and correlations with immunological responses.

Liu L, Gong YX, Zhu B, Liu GL, Wang GX, Ling F.

Fish Shellfish Immunol. 2015 Apr 8. pii: S1050-4648(15)00152-7. doi: 10.1016/j.fsi.2015.03.043. [Epub ahead of print]

PMID: 25862971

Related citations

Select item 25862953 105.

Observed parent-child relationship quality predicts antibody response to vaccination in children.

O'Connor TG, Wang H, Moynihan JA, Wyman PA, Carnahan J, Lofthus G, Quataert SA, Bowman M, Burke AS, Caserta MT.

Brain Behav Immun. 2015 Apr 9. pii: S0889-1591(15)00087-2. doi: 10.1016/j.bbi.2015.04.002. [Epub ahead of print]

PMID: 25862953

Related citations

Select item 25862815 106.

DEC205+ Dendritic Cell-Targeted Tolerogenic Vaccination Promotes Immune Tolerance in Experimental Autoimmune Arthritis.

Spiering R, Margry B, Keijzer C, Petzold C, Hoek A, Wagenaar-Hilbers J, van der Zee R, van Eden W, Kretschmer K, Broere F.

J Immunol. 2015 Apr 10. pii: 1400986. [Epub ahead of print]

PMID: 25862815

Related citations

Select item 25862725 107.

Rotavirus vaccination in preterm infants: a neonatal guidance chart to aid timely immunisation.

Kilich E, Anthony M.

Arch Dis Child Fetal Neonatal Ed. 2015 Apr 10. pii: fetalneonatal-2015-308381. doi: 10.1136/archdischild-2015-308381. [Epub ahead of print] No abstract available.

PMID: 25862725

Related citations

Select item 25862449 108.

Thiomersal-containing vaccines - a review of the current state of knowledge.

Gołoś A, Lutyńska A.

Przegl Epidemiol. 2015;69(1):59-64. English, Polish.

PMID: 25862449 Free Article

Related citations

Select item 25862448 109.

Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.

Owsianka B, Gańczak M.

Przegl Epidemiol. 2015;69(1):53-8. English, Polish.

PMID: 25862448 Free Article

Related citations

Select item 25862447 110.

Current views on the persistence of immunity following hepatitis B vaccination.

Madaliński K, Kołakowska A, Godzik P.

Przegl Epidemiol. 2015;69(1):47-51. English, Polish.

PMID: 25862447 Free Article

Related citations

Select item 25862444 111.

Impact of vaccination against HBV on hepatitis B incidence in Opolskie province in 2007-2011.

Matejuk A, Simon K.

Przegl Epidemiol. 2015;69(1):27-31. English, Polish.

PMID: 25862444 Free Article

Related citations

Select item 25862300 112.

An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures.

Pereira RC, Silva AN, Souza MC, Silva MV, Neves PP, Silva AA, Matos DD, Herrera MA, Yamamura AM, Freire MS, Gaspar LP, Caride E.

Vaccine. 2015 Apr 7. pii: S0264-410X(15)00396-5. doi: 10.1016/j.vaccine.2015.03.077. [Epub ahead of print]

PMID: 25862300

Related citations

Select item 25862299 113.

A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe.

Geldenhuys HD, Mearns H, Foster J, Saxon E, Kagina B, Saganic L, Jarrahian C, Tameris MD, Dintwe OB, Van Rooyen M, Luabeya KK, Hussey G, Scriba TJ, Hatherill M, Zehrung D.

Vaccine. 2015 Apr 7. pii: S0264-410X(15)00393-X. doi: 10.1016/j.vaccine.2015.03.074. [Epub ahead of print]

PMID: 25862299 Free Article

Related citations

Select item 25862196 114.

Present situation and challenges of vaccinations for overseas travelers from Japan.

Hamada A, Fukushima S.

J Infect Chemother. 2015 Mar 20. pii: S1341-321X(15)00071-9. doi: 10.1016/j.jiac.2015.03.006. [Epub ahead of print] Review.

PMID: 25862196

Related citations

Select item 25862072 115.

Development of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant.

Rivas-Aravena A, Fuentes Y, Cartagena J, Brito T, Poggio V, La Torre J, Mendoza H, Gonzalez F, Sandino AM, Spencer E.

Fish Shellfish Immunol. 2015 Apr 7. pii: S1050-4648(15)00142-4. doi: 10.1016/j.fsi.2015.03.033. [Epub ahead of print]

PMID: 25862072

Related citations

Select item 25861656 116.

HIV Vaccine Research: The Challenge and the Way Forward.

Wang HB, Mo QH, Yang Z.

J Immunol Res. 2015;2015:503978. Epub 2015 Mar 15. Review.

PMID: 25861656 Free PMC Article

Related citations

Select item 25861435 117.

Post-vaccination Immunity Against Hepatitis B Virus and Predictors for Non- responders Among Medical Staff.

Nashibi R, Alavi SM, Yousefi F, Salmanzadeh S, Moogahi S, Ahmadi F, Farashahinejad M.

Jundishapur J Microbiol. 2015 Mar 21;8(3):e19579. doi: 10.5812/jjm.19579. eCollection 2015 Mar.

PMID: 25861435 Free PMC Article

Related citations

Select item 25860618 118.

Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

Lin M, Yuan YY, Liu SP, Shi JJ, Long XA, Niu LZ, Chen JB, Li Q, Xu KC.

J Cancer Res Clin Oncol. 2015 Apr 10. [Epub ahead of print]

PMID: 25860618

Related citations

Select item 25860532 119.

European Society for Paediatric Infectious Diseases Consensus Recommendations for Rotavirus Vaccination in Europe. Update 2014.

Vesikari T, Van Damme P, Giaquinto C, Dagan R, Guarino A, Szajewska H, Usonis V.

Pediatr Infect Dis J. 2015 Apr 8. [Epub ahead of print]

PMID: 25860532

Related citations

Select item 25860463 120.

Impact of the antipneumococcal conjugate vaccine on the occurrence of infectious respiratory diseases and hospitalization rates in children.

Abrão WM, Mello LM, Silva AS, Nunes AA.

Rev Soc Bras Med Trop. 2015 Jan-Feb;48(1):44-9. doi: 10.1590/0037-8682-0007- 2015. Epub 2015 Jan 1.

PMID: 25860463

Free Article

Related citations

Select item 25860002 121.

Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.

Hesseling AC, Jaspan HB, Black GF, Nene N, Walzl G.

Int J Tuberc Lung Dis. 2015 Apr;19(4):454-62. doi: 10.5588/ijtld.14.0608.

PMID: 25860002

Related citations

Select item 25859680 122.

Communicating vaccine safety to the media and general public.

Oubari H, Tuttle R, Rath B, Bravo L.

Curr Drug Saf. 2015;10(1):80-6.

PMID: 25859680

Related citations

Select item 25859679 123.

The need to teach vaccine safety to basic scientists and public health officials.

Khamesipour A.

Curr Drug Saf. 2015;10(1):76-9.

PMID: 25859679

Related citations

Select item 25859678 124.

Communicating vaccine safety in the context of immunization programs in low resource settings.

Arwanire EM, Mbabazi W, Mugyenyi P. 42

Curr Drug Saf. 2015;10(1):68-75.

PMID: 25859678

Related citations

Select item 25859677 125.

Vaccine safety monitoring systems in developing countries: an example of the Vietnam model.

Ali M, Rath B, Thiem VD.

Curr Drug Saf. 2015;10(1):60-7.

PMID: 25859677

Related citations

Select item 25859676 126.

Communicating vaccine safety during the development and introduction of vaccines.

Kochhar S.

Curr Drug Saf. 2015;10(1):55-9.

PMID: 25859676

Related citations

Select item 25859675 127.

Importance of Vaccine Safety in Children with Chronic Conditions - Experience at the Scientific Centre for Children's Health in Moscow, Russia.

Grechukha TA, Galitskaya MG, Namazova-Baranova LS.

Curr Drug Saf. 2015;10(1):49-54.

PMID: 25859675

Related citations

Select item 25859674 128.

Controlled language and information on vaccines: application to package inserts.

Renahy J, Vuitton DA, Rath B, Thomas I, de Grivel V, Cardey S.

Curr Drug Saf. 2015;10(1):41-8.

PMID: 25859674

Related citations

Select item 25859673 129.

A design thinking approach to effective vaccine safety communication.

Seeber L, Michl B, Rundblad G, Trusko B, Schnjakin M, Meinel C, Weinberg U, Gaedicke G, Rath B.

Curr Drug Saf. 2015;10(1):31-40.

PMID: 25859673

Related citations

Select item 25859672 130.

The importance of precise documentation of vaccination by physicians and vaccine providers.

Maurer W.

Curr Drug Saf. 2015;10(1):27-30.

PMID: 25859672

Related citations

Select item 25859671 131.

Teaching vaccine safety communication to medical students and health professionals.

Rath B, Muhlhans S, Gaedicke G.

Curr Drug Saf. 2015;10(1):23-6.

PMID: 25859671

Related citations

Select item 25859670 132.

The impact of the parent-physician relationship on parental vaccine safety perceptions.

Kundi M, Obermeier P, Helfert S, Oubari H, Fitzinger S, Yun JA, Brix M, Rath B.

Curr Drug Saf. 2015;10(1):16-22.

PMID: 25859670

Related citations

Select item 25859669 133.

Risk communication of vaccines: challenges in the post-trust environment.

Bouder F.

Curr Drug Saf. 2015;10(1):9-15.

PMID: 25859669

Related citations

Select item 25859668 134.

Historical aspects of immunization and vaccine safety communication.

Helfert SM.

Curr Drug Saf. 2015;10(1):5-8.

PMID: 25859668

Related citations

Select item 25859667 135.

Editorial: communicating vaccine safety - the vienna vaccine safety initiative.

Rath B.

Curr Drug Saf. 2015;10(1):3-4. No abstract available.

PMID: 25859667

Related citations

Select item 25859081 136.

HPV vaccine: Current status and future directions.

Kumar S, Biswas M, Jose T.

Med J Armed Forces India. 2015 Apr;71(2):171-7. doi: 10.1016/j.mjafi.2015.02.006. Epub 2015 Mar 13. Review.

PMID: 25859081

Related citations

Select item 25858958 137.

Neuraminidase: another piece of the influenza vaccine puzzle.

Eckard L, Webby R.

J Infect Dis. 2015 Apr 8. pii: jiv196. [Epub ahead of print] No abstract available.

PMID: 25858958

Related citations

Select item 25858956 138.

The diversity of meningococcal carriage across the African meningitis belt and the impact of vaccination with a group A meningococcal conjugate vaccine.

African Meningococcal Carriage Consortium.

J Infect Dis. 2015 Apr 9. pii: jiv211. [Epub ahead of print]

PMID: 25858956

Related citations

Select item 25858860 139.

Systems vaccinology: Enabling rational vaccine design with systems biological approaches. 46

Hagan T, Nakaya HI, Subramaniam S, Pulendran B.

Vaccine. 2015 Apr 6. pii: S0264-410X(15)00391-6. doi: 10.1016/j.vaccine.2015.03.072. [Epub ahead of print]

PMID: 25858860

Related citations

Select item 25858859 140.

An experimental subunit vaccine based on Bluetongue virus 4 VP2 protein fused to an antigen-presenting cells single chain antibody elicits cellular and humoral immune responses in cattle, guinea pigs and IFNAR(-/-) mice.

Legisa DM, Perez Aguirreburualde MS, Gonzalez FN, Marin-Lopez A, Ruiz V, Wigdorovitz A, Escribano JA, Ortego J, Dus Santos MJ.

Vaccine. 2015 Apr 6. pii: S0264-410X(15)00386-2. doi: 10.1016/j.vaccine.2015.03.067. [Epub ahead of print]

PMID: 25858859

Related citations

Select item 25858856 141.

Molecular signatures for vaccine development.

Maertzdorf J, Kaufmann SH, Weiner J 3rd.

Vaccine. 2015 Apr 6. pii: S0264-410X(15)00394-1. doi: 10.1016/j.vaccine.2015.03.075. [Epub ahead of print]

PMID: 25858856

Related citations

Select item 25858855 142.

Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.

Li J, Ge J, Ren S, Zhou T, Sun Y, Sun H, Gu Y, Huang H, Xu Z, Chen X, Xu X.

Vaccine. 2015 Apr 6. pii: S0264-410X(15)00398-9. doi: 10.1016/j.vaccine.2015.03.079. [Epub ahead of print]

PMID: 25858855

Related citations

Select item 25858854 143.

Multifunctional liposomes constituting microneedles induced robust systemic and mucosal immunoresponses against the loaded antigens via oral mucosal vaccination.

Zhen Y, Wang N, Gao Z, Ma X, Wei B, Deng Y, Wang T.

Vaccine. 2015 Apr 6. pii: S0264-410X(15)00400-4. doi: 10.1016/j.vaccine.2015.03.081. [Epub ahead of print]

PMID: 25858854

Related citations

Select item 25858415 144.

Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA.

Li J, Arévalo MT, Diaz-Arévalo D, Chen Y, Choi JG, Zeng M.

J Control Release. 2015 Apr 6. pii: S0168-3659(15)00219-9. doi: 10.1016/j.jconrel.2015.04.001. [Epub ahead of print]

PMID: 25858415

Related citations

Select item 25858230 145.

Vaccines for visceral leishmaniasis: A review.

Jain K, Jain NK.

J Immunol Methods. 2015 Apr 7. pii: S0022-1759(15)00093-9. doi: 10.1016/j.jim.2015.03.017. [Epub ahead of print] Review.

PMID: 25858230

Related citations

Select item 25857850 146.

Epitope -based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study.

Khan MA, Hossain MU, Rakib-Uz-Zaman SM, Morshed MN.

Scand J Immunol. 2015 Apr 10. doi: 10.1111/sji.12302. [Epub ahead of print]

PMID: 25857850

Related citations

Select item 25857736 147.

Vaccination with nontoxic mutant toxic shock syndrome toxin-1 induces IL-17- dependent protection against Staphylococcus aureus infection.

Narita K, Hu DL, Asano K, Nakane A.

Pathog Dis. 2015 Apr 9. pii: ftv023. [Epub ahead of print]

PMID: 25857736

Related citations

Select item 25857701 148.

Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings.

Poletti P, Merler S, Ajelli M, Manfredi P, Munywoki PK, Nokes D, Melegaro A.

BMC Med. 2015 Mar 10;13(1):49. doi: 10.1186/s12916-015-0283-x.

PMID: 25857701 Free PMC Article

Related citations

Select item 25857506 149.

Antibody response to hepatitis B vaccination in isolated anti-HBc positive subjects.

Gozdas HT.

Indian J Med Res. 2015 Jan;141(1):125-6. No abstract available.

PMID: 25857506 49

Free Article

Related citations

Select item 25857236 150.

Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis.

Remschmidt C, Wichmann O, Harder T.

BMC Med. 2015 Mar 17;13(1):53. doi: 10.1186/s12916-015-0295-6.

PMID: 25857236 Free PMC Article

Related citations

Select item 25857143 151.

[Current status and future perspective of peptide vaccine for biliary tract cancer].

Aruga A.

Nihon Rinsho. 2015 Mar;73 Suppl 3:823-6. Japanese. No abstract available.

PMID: 25857143

Related citations

Select item 25857063 152.

[Present and future status of therapeutic cancer peptide vaccine therapy for patients with pancreatic cancer].

Katsuda M, Yamaue H.

Nihon Rinsho. 2015 Mar;73 Suppl 3:433-7. Japanese. No abstract available.

PMID: 25857063

Related citations

Select item 25856891 153.

[Effect of Lep d2 from Lepidoglyphus destructor as a vaccine for specific immunotherapy in murine with asthma]. 50

Lu W, Li N, Xie JZ, Li CP.

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2014 Dec;26(6):648-51. Chinese.

PMID: 25856891

Related citations

Select item 25856888 154.

[Preliminary studies on effect of polysaccharides from Tegillarca granosa as an adjuvant on DNA vaccine against Schistosoma japonicum infection].

Tang XN, Kong FW, Zhan XD.

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2014 Dec;26(6):632-5 . Chinese.

PMID: 25856888

Related citations

AMEDEO - Vaccines Publicaciones (13 - 04 - 2015): 42 artículos nuevos.

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

39. COPIN R, Coscolla M, Efstathiadis E, Gagneux S, et al. Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG). Vaccine. 2014;32:5998-6004. PubMed: www.amedeo.com/p2.php?id=25211768&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25211768

Vacunas neumococo (Streptococcus pneumoniae)

3. VAN WESTEN E, Wijmenga-Monsuur AJ, van Dijken HH, van Gaans-van den Brink JA, et al. Differential B cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2015. PubMed: www.amedeo.com/p2.php?id=25838290&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25838290

7. PALKOLA NV, Pakkanen SH, Kantele JM, Pakarinen L, et al. Differences in homing potentials of Pnc-specific plasmablasts in pneumococcal pneumonia and after PPV and PCV vaccinations. J Infect Dis. 2015. PubMed: www.amedeo.com/p2.php?id=25838267&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25838267

Vacunas fiebre tifoidea (Salmonella typhi)

14. WAIN J, Hendriksen RS, Mikoleit ML, Keddy KH, et al. Typhoid fever. Lancet. 2015;385:1136-45. PubMed: www.amedeo.com/p2.php?id=25458731&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25458731

Vacunas cólera (Vibrio cholerae)

22. WIERZBA TF, Kar SK, Mogasale VV, Kerketta AS, et al. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India. Vaccine. 2015 Apr 4. pii: S0264-410X(15)00392. PubMed: www.amedeo.com/p2.php?id=25850019&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25850019

Vacunas dengue

4. BALASUBRAMANIAN S. Tetravalent dengue vaccine for children: pediatricians viewpoint. Indian Pediatr. 2015;52:239-40. PubMed: www.amedeo.com/p2.php?id=25849004&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/25849004

5. AGGARWAL A. Tetravalent dengue vaccine for children: vaccinologists viewpoint. Indian Pediatr. 2015;52:239. PubMed: www.amedeo.com/p2.php?id=25849003&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/25849003

6. MATHEW JL. Tetravalent Dengue Vaccine for Children: Evidence-based-medicine Viewpoint. Indian Pediatr. 2015;52:237-9. PubMed: www.amedeo.com/p2.php?id=25849002&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/25849002

Vacunas, otras

1. RAINONE V, Giacomet V, Penagini F, Fabiano V, et al. Human papilloma virus vaccination induces strong human papilloma virus specific cell-mediated immune responses in HIV-infected adolescents and young adults. AIDS. 2015;29:739-43. PubMed: www.amedeo.com/p2.php?id=25849837&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25849837

2. LIU Q, Li Y, Luo Z, Yang G, et al. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection. AIDS. 2015;29:649-58. PubMed: www.amedeo.com/p2.php?id=25849828&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25849828

3. VAN WESTEN E, Wijmenga-Monsuur AJ, van Dijken HH, van Gaans- van den Brink JA, et al. Differential B cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2015. PubMed: www.amedeo.com/p2.php?id=25838290&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25838290

5. AGGARWAL A. Tetravalent dengue vaccine for children: vaccinologists viewpoint. Indian Pediatr. 2015;52:239. PubMed: www.amedeo.com/p2.php?id=25849003&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25849003

6. MATHEW JL. Tetravalent Dengue Vaccine for Children: Evidence-based-medicine Viewpoint. Indian Pediatr. 2015;52:237-9. PubMed: www.amedeo.com/p2.php?id=25849002&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25849002

8. HALLILEY JL, Khurana S, Krammer F, Fitzgerald T, et al. High Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine after Priming with Live Attenuated Influenza Vaccine. J Infect Dis. 2015. PubMed: www.amedeo.com/p2.php?id=25838266&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25838266

9. KIM E, Okada K, Beeler JA, Crim RL, et al. Correction for kim et Al., development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model. J Virol. 2015;89:5193. PubMed: www.amedeo.com/p2.php?id=25841050&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25841050

10. KRAATZ F, Wernike K, Hechinger S, Konig P, et al. Deletion mutants of Schmallenberg virus are avirulent and protect from virus challenge. J Virol. 2015;89:1825-37. PubMed: www.amedeo.com/p2.php?id=25410877&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25410877

11. RAPPUOLI R. What are affordable vaccines? Lancet. 2015;385:1177-8. PubMed: www.amedeo.com/p2.php?id=25845785&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25845785

12. HEYMANN DL, Rodier GR, Ryan MJ. Ebola vaccines: keep the clinical trial protocols on the shelf and ready to roll out. Lancet. 2015 Apr 2. pii: S0140-6736(15)60645. PubMed: www.amedeo.com/p2.php?id=25843891&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25843891

13. AZMAN AS, Legros D, Lessler J, Luquero FJ, et al. Outbreaks of cholera in the time of Ebola: pre-emptive action needed. Lancet. 2015;385:851.

PubMed: www.amedeo.com/p2.php?id=25703455&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25703455

15. Long-Term Efficacy of a Hepatitis E Vaccine. N Engl J Med. 2015;372:1478. PubMed: www.amedeo.com/p2.php?id=25853767&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25853767

16. VORA NM, Li Y, Geleishvili M, Emerson GL, et al. Human infection with a zoonotic orthopoxvirus in the country of Georgia. N Engl J Med. 2015;372:1223-30. PubMed: www.amedeo.com/p2.php?id=25806914&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25806914

17. MARILL MC. After flu vaccine mismatch, calls for delayed selection intensify. Nat Med. 2015;21:297-8. PubMed: www.amedeo.com/p2.php?id=25849262&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25849262

18. LIPSITCH M, Eyal N, Halloran ME, Hernan MA, et al. Vaccine testing. Ebola and beyond. Science. 2015;348:46-8. PubMed: www.amedeo.com/p2.php?id=25838371&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25838371

19. CARRENO BM, Magrini V, Becker-Hapak M, Kaabinejadian S, et al. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015 Apr 2. pii: aaa3828. PubMed: www.amedeo.com/p2.php?id=25837513&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25837513

20. KING JC JR, Gao Y, Quinn CP, Dreier TM, et al. Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents. Vaccine. 2015 Apr 4. pii: S0264-410X(15)00390. PubMed: www.amedeo.com/p2.php?id=25850022&s=vac&pm=badc2a9eebb0fad ABSTRACT available

Share: http://m.amedeo.com/25850022

21. GANY F, Rau-Murthy R, Mujawar I. Increasing influenza vaccination in New York City taxi drivers: A community driven approach. Vaccine. 2015 Apr 4. pii: S0264-410X(15)00326. PubMed: www.amedeo.com/p2.php?id=25850021&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25850021

23. CADORNA-CARLOS JB, Nolan T, Borja-Tabora CF, Santos J, et al. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial. Vaccine. 2015 Apr 2. pii: S0264-410X(15)00384. PubMed: www.amedeo.com/p2.php?id=25843270&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25843270

24. WANG F, Shen L, Cui F, Zhang S, et al. The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China. Vaccine. 2015 Apr 2. pii: S0264-410X(15)00383. PubMed: www.amedeo.com/p2.php?id=25843269&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25843269

25. MICHEL R, Berger F, Ravelonarivo J, Dussart P, et al. Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines? Vaccine. 2015 Apr 2. pii: S0264-410X(15)00388. PubMed: www.amedeo.com/p2.php?id=25843268&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25843268

26. HARMSEN MM, Fijten HP, Westra DF, Dekker A, et al. Stabilizing effects of excipients on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles during storage as oil-emulsion vaccine. Vaccine. 2015 Apr 2. pii: S0264-410X(15)00385. PubMed: www.amedeo.com/p2.php?id=25843267&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25843267

27. CANFELL K, Egger S, Velentzis LS, Brown JD, et al. Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study. Vaccine. 2015 Apr 2. pii: S0264-410X(15)00043. PubMed: www.amedeo.com/p2.php?id=25843203&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25843203

28. TAO W, Gill HS. M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection. Vaccine. 2015 Apr 1. pii: S0264-410X(15)00382. PubMed: www.amedeo.com/p2.php?id=25842219&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25842219

29. JACOBY E, Jarrahian C, Hull HF, Zehrung D, et al. Opportunities and challenges in delivering influenza vaccine by microneedle patch. Vaccine. 2015 Apr 1. pii: S0264-410X(15)00381. PubMed: www.amedeo.com/p2.php?id=25842218&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25842218

30. HELMUTH IG, Poulsen A, Suppli CH, Molbak K, et al. Varicella in Europe-A review of the epidemiology and experience with vaccination. Vaccine. 2015 Mar 31. pii: S0264-410X(15)00365. PubMed: www.amedeo.com/p2.php?id=25839105&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25839105

31. PEARSON FE, O'Mahony C, Moore AC, Hill AV, et al. Induction of CD8 T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine. Vaccine. 2015 Mar 31. pii: S0264-410X(15)00338. PubMed: www.amedeo.com/p2.php?id=25839104&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25839104

32. DEREUDDRE-BOSQUET N, Baron ML, Contreras V, Gosse L, et al. HIV specific responses induced in nonhuman primates with ANRS HIV-Lipo-5 vaccine combined with rMVA-HIV prime or boost immunizations. Vaccine. 2015 Mar 31. pii: S0264-410X(15)00331. PubMed: www.amedeo.com/p2.php?id=25839103&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25839103

33. MYERS HI, Spracklen CN, Ryckman KK, Murray JC, et al. A retrospective study of administration of vaccination for hepatitis B among newborn infants prior to hospital discharge at a midwestern tertiary care center. Vaccine. 2015 Mar 30. pii: S0264-410X(15)00361. PubMed: www.amedeo.com/p2.php?id=25835577&s=vac&pm=badc2a9eebb0fad

ABSTRACT available Share: http://m.amedeo.com/25835577

34. GREEN HK, Andrews N, Letley L, Sunderland A, et al. Phased introduction of a universal childhood influenza vaccination programme in England: Population-level factors predicting variation in national uptake during the first year, 2013-14. Vaccine. 2015 Mar 30. pii: S0264-410X(15)00357. PubMed: www.amedeo.com/p2.php?id=25835576&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25835576

35. RAHN J, Hoffmann D, Harder TC, Beer M, et al. Vaccines against influenza A viruses in poultry and swine: Status and future developments. Vaccine. 2015 Mar 30. pii: S0264-410X(15)00360. PubMed: www.amedeo.com/p2.php?id=25835575&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25835575

36. SMITH M, Peacock G, Uyeki TM, Moore C, et al. Influenza vaccination in children with neurologic or neurodevelopmental disorders. Vaccine. 2015 Mar 30. pii: S0264-410X(15)00358. PubMed: www.amedeo.com/p2.php?id=25835574&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25835574

37. PUANGPETCH A, Anderson R, Huang YY, Saengsot R, et al. Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challenge. Vaccine. 2014;32:5983-8. PubMed: www.amedeo.com/p2.php?id=25223269&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25223269

38. URBIZTONDO L, Bayas JM, Broner S, Costa J, et al. Varicella-zoster virus immunity among health care workers in Catalonia. Vaccine. 2014;32:5945-8. PubMed: www.amedeo.com/p2.php?id=25219564&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25219564

40. THOON KC, Tee NW, Chew L, Chong CY, et al.

Near disappearance of childhood invasive Haemophilus influenzae type b disease in Singapore. Vaccine. 2014;32:5862-5. PubMed: www.amedeo.com/p2.php?id=25173480&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173480

41. ABU RAYA B, Srugo I, Kessel A, Peterman M, et al. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study. Vaccine. 2014;32:5787-93. PubMed: www.amedeo.com/p2.php?id=25173476&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173476

42. KIM MC, Lee YN, Hwang HS, Lee YT, et al. Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity. Vaccine. 2014 Aug 26. pii: S0264-410X(14)01153. PubMed: www.amedeo.com/p2.php?id=25171841&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25171841

PATENTES

United States Patent and Trademark Office (USPTO)

Estrategia de búsqueda “vaccine” en título y abstract

(ABST/vaccine AND ISD/20150405->20150417): 10 patentes recuperadas.

Vacunas meningococo (Neisseria meningitidis)

8 8,999,354 Multivalent meningococcal polysaccharide-protein conjugate vaccine

Vacunas, otras

PAT. Title NO.

1 9,006,184 Cancer vaccine composition

2 9,005,961 Infectious cDNA of an approved vaccine strain of measles

virus, use for immunogenic compositions

3 9,005,925 Infectious cDNA of an approved vaccine strain of measles

virus, use for immunogenic compositions

4 9,005,633 Psoralen-inactivated viral vaccine and method of preparation

5 9,005,632 Compositions, methods and uses for poxvirus elements in

vaccine constructs against influenza virus subtypes or strains

6 9,005,630 Fusion proteins for the treatment of allergic diseases

7 9,000,136 Recombinant vaccinia virus having hepatitis C virus gene

8 8,999,354 Multivalent meningococcal polysaccharide-protein conjugate

vaccine

9 8,999,352 Genetically engineered swine influenza virus and uses

thereof

10 8,999,319 Oral vaccination of fish with live attenuated Edwardsiella

ictaluri vaccines

European Patent Office (EPO)

Acumulado entre el 5 y el 17 de abril de 2015: 18 patentes recuperadas

Vacuna tuberculosis (Mycobacterium tuberculosis)

11. TUBERCULOSIS VACCINE AND METHOD OF USING SAME

Inventor: Priorit CPC: Applicant: Publication info: y LIGHTER IPC: A61K2039/521 date: JENNIFER [US] MICO BIO INC HRP20150177 (T1) A61K39/04 A61K39/04 FISHER JASON [US] 2015-04-10 2007- A61K9/0073 [US] 04-12

Vacunas, otras

1. INJECTABLE VACCINE COMPOSITION

Inventor: IPC: Priority MATSUSHITA Applicant: Publication info: A61K39/00 date: KYOHEI [JP] CPC: NITTO DENKO A61K39/39 WO2015050181 (A1) FUKASAKA 2013- CORP [JP] A61P37/04 2015-04-09 MASAHIRO [JP] 10-03 (+2) (+5)

2. MUCOSAL VACCINE COMPOSITION

Inventor: IPC: Priority FUKASAKA Applicant: Publication info: MASAHIRO [JP] A61K39/39 date: CPC: HORI NITTO DENKO A61K9/06 WO2015050180 (A1) 2013- MITSUHIKO CORP [JP] A61K9/08 2015-04-09 10-03 [JP] (+7) (+5)

3. MUCOSAL VACCINE COMPOSITION

Inventor: IPC: Priority FUKASAKA Applicant: Publication info: MASAHIRO [JP] A61K39/39 date: CPC: HORI NITTO DENKO A61K9/06 WO2015050179 (A1) 2013- MITSUHIKO CORP [JP] A61K9/08 2015-04-09 10-03 [JP] (+2) (+5)

4. NASAL MUCOSAL VACCINE COMPOSITION

Inventor: IPC: Priority KIYOTOH EIJI Applicant: Publication info: A61K39/02 date: [JP] CPC: NITTO DENKO A61K39/12 WO2015050178 (A1) HORI 2013- CORP [JP] A61K39/39 2015-04-09 MITSUHIKO 10-03 (+2) [JP]

(+5)

5. DRIED INFLUENZA VACCINE PREPARATION AND METHOD FOR PRODUCING DRIED INFLUENZA VACCINE PREPARATION

Inventor: IPC: Priority KIYOTOH EIJI Applicant: Publication info: [JP] A61K39/145 date: CPC: HORI NITTO DENKO A61K47/26 WO2015050177 (A1) 2013- MITSUHIKO CORP [JP] A61K9/19 2015-04-09 10-03 [JP] (+1) (+3)

6. T CELL-INDUCING VACCINE CONTAINING INTEREPITOPE SEQUENCE PROMOTING ANTIGEN PRESENTATION

Inventor: Applicant: IPC: Priority SHIKU HIROSHI Publication info: UNIV MIE A61K39/00 date: [JP] CPC: [JP] A61K47/36 WO2015050158 (A1) HARADA 2013- UNIV KYOTO A61K48/00 2015-04-09 NAOZUMI [JP] 10-01 [JP] (+4) (+2)

7. HAEMOPHILUS PARASUIS VACCINE SEROVAR TYPE FOUR

Inventor: CPC: Priority LAWRENCE Applicant: Publication info: PAULRAJ A61K2039/521 IPC: date:

KIRUBAKARAN MERIAL LTD A61K2039/552 US2015098968 (A1) A61K39/102 2013- [US] [US] A61K2039/70 2015-04-09 10-04 BEY RUSSELL F (+2) [US]

8. ROTAVIRUS VACCINE COMPOSITIONS AND PROCESS FOR PREPARING THE SAME

Inventor: CPC: IPC: Applicant: Priority VADREVU Publication info: KRISHNA A61K2039/55505 A61K39/15 date: BHARAT MOHAN [IN] A61K2039/55511 A61K39/39 US2015098967 (A1) BIOTECH INT 2012- PRASAD SAI A61K39/12 A61K47/26 2015-04-09 LTD [IN] 04-23 DEVARAJULU (+5) (+1) [IN]

9. SUPPRESSOR CELL FUNCTION INHIBITION FOLLOWING LISTERIA VACCINE TREATMENT

Inventor: CPC: Priority Applicant: IPC: Publication info: SINGH RESHMA A61K2035/11 date:

[US] ADVAXIS INC A61K2039/522 A61K35/74 US2015098964 (A1) 2012- WALLECHA ANU [US] A61K2039/523 A61K39/02 2015-04-09 03-12 [US] (+8)

10. PCSK9 VACCINE

Inventor: Applicant: CPC: Priority IPC: Publication info: date: CHAMPION CHAMPION A61K39/0005 A61K39/00 US2015098957 (A1) BRIAN ROBERT BRIAN C12N9/6424 2009- C12N9/64 2015-04-09 [GB] ROBERT [GB] C12Y304/21061 09-03

CONTILLO JR CONTILLO JR LEONARD LEONARD GABRIEL [US] GABRIEL [US] (+8) (+9)

11. TUBERCULOSIS VACCINE AND METHOD OF USING SAME

Inventor: CPC: Priority Applicant: Publication info: LIGHTER IPC: date: A61K2039/521 JENNIFER [US] MICO BIO INC HRP20150177 (T1) A61K39/04 A61K39/04 2007- FISHER JASON [US] 2015-04-10 A61K9/0073 04-12 [US]

12. OMV vaccine against Burkholderia infections

IPC: CPC: Priority Inventor: Applicant: Publication info: A61K35/74 date: A61K2039/543 MORICI LISA A UNIV TULANE A61K39/02 GB2518813 (A) A61K2039/55505 2011- [US] [US] A61K39/104 2015-04-08 (+12) 01-12 (+4)

13. Cytokine-expressing cellular vaccine combinations

Inventor: CPC: IPC: Priority JOOSS KARIN Applicant: Publication info: A61K2039/505 A61K38/19 date: [US] ADURO GVAX A61K2039/5156 A61K38/20 EP2859901 (A1) CRESON 2003- INC [US] A61K2039/5158 A61K38/21 2015-04-15 JENNIFER [US] 04-02 (+12) (+4) (+5)

14. THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1

Inventor: Applicant: CPC: Priority TRZONKOWSKI IPC: Publication info: PIOTR [PL] GDANSKI A61K2039/5158 date:

MYSLIWIEC UNIV A61K2039/55 A61K35/26 EP2859092 (A1) 2012- MALGORZATA MEDYCZNY A61K35/17 C12N5/0783 2015-04-15 06-06 [PL] [PL] (+3) (+1)

15. HIV VACCINE

Inventor: IPC: Applicant: CPC: Priority SÖRENSEN Publication info: A61K31/00 date: BIRGER [NO] BIONOR A61K2039/55566 A61K31/19 EP2858667 (A1) ÖKVIST MATS IMMUNO AS A61K2300/00 2012- A61K39/00 2015-04-15 [NO] [NO] (+12) 06-06 (+1) (+5)

16. GENETICALLY MODIFIED SCHMALLENBERG VIRUS (SBV) FOR USE AS VACCINE

Inventor: Applicant: CPC: IPC: Priority Publication info: date: ELLIOT UNIV A01K2227/101 A01K67/027 EP2859094 (A1) RICHARD M GLASGOW A01K2227/102 A61K39/12 2012- 2015-04-15 [GB] [GB] A01K67/027 C12N7/00 06-11

BLAKQORI GJON (+9) [US] (+3)

17. SCHMALLENBERG VIRUS (SBV) VACCINE, METHODS OF PRODUCTION, AND USES THEREOF

Inventor: CPC: Applicant: Priority NIKOLIN IPC: Publication info: A61K2039/5252 date: VELJKO [DE] BOEHRINGER A61K2039/552 A61K39/12 EP2855513 (A1) STADLER INGELHEIM 2012- A61K2039/55505 C07K14/175 2015-04-08 KONRAD [DE] VETMED [DE] 06-01 (+5) (+4)

18. HERPES SIMPLEX VIRUS VACCINE

Inventor: CPC: IPC: Priority WEI LISA [US] Applicant: Publication info: A61K2039/53 date: BROUGH A61K39/245 GENVEC INC A61K2039/545 EP2855511 (A1) DOUGLAS E C07K14/035 2012- [US] A61K39/245 2015-04-08 [US] C12N15/861 05-29 (+6) (+1)

TABLAS DE CONTENIDO

Revista Vaccine

Tabla de Contenidos. Volume 33, Issue 18, Pages 2097 - 2196, (27 April, 2015)

Editorial Board/Aims and Scope Pages IFC

Reviews

Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014 Review Article Pages 2097-2107 Emilie Karafillakis, Sondus Hassounah, Christina Atchison

Influenza vaccination during pregnancy: A systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes Review Article Pages 2108-2117 M. McMillan, K. Porritt, D. Kralik, L. Costi, H. Marshall

Regular papers

Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: The Mycobacterium abscessus model Original Research Article Pages 2118-2124 Vincent Le Moigne, Martin Rottman, Celine Goulard, Benoit Barteau, Isabelle Poncin, Nathalie Soismier, Stephane Canaan, Bruno Pitard, Jean-Louis Gaillard, Jean-Louis Herrmann

Influenza and pertussis vaccination coverage in pregnant women Original Research Article Pages 2125-2131 Jolien Laenen, Mathieu Roelants, Roland Devlieger, Corinne Vandermeulen

M-M-R®II manufactured using recombinant human albumin (rHA) and M-M-R®II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children Original Research Article Pages 2132-2140 Richard T. Wiedmann, Keith S. Reisinger, Jonathan Hartzel, Edgardo Malacaman, Shelly D. Senders, Katherine E.D. Giacoletti, Eric Shaw, Barbara J. Kuter, Florian Schodel, Luwy K. Musey

Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica Original Research Article Pages 2141-2151 Paula Gonzalez, Allan Hildesheim, Rolando Herrero, Hormuzd Katki, Sholom Wacholder, Carolina Porras, Mahboobeh Safaeian, Silvia Jimenez, Teresa M. Darragh, Bernal Cortes, Brian Befano, Mark Schiffman, Loreto Carvajal, Joel Palefsky, John Schiller, Rebeca Ocampo, John Schussler, Douglas Lowy, Diego Guillen, Mark H. Stoler,

Wim Quint, Jorge Morales, Carlos Avila, Ana Cecilia Rodriguez, Aimee R. Kreimer, for the Costa Rica HPV Vaccine Trial (CVT) Group

Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets Original Research Article Pages 2152-2158 Ye V. Liu, Michael J. Massare, Melissa B. Pearce, Xiangjie Sun, Jessica A. Belser, Taronna R. Maines, Hannah M. Creager, Gregory M. Glenn, Peter Pushko, Gale E. Smith, Terrence M. Tumpey

Outer membrane proteins preferentially load MHC class II peptides: Implications for a Chlamydia trachomatis T cell vaccine Original Research Article Pages 2159-2166 Karuna P. Karunakaran, Hong Yu, Xiaozhou Jiang, Queenie Chan, Kyung-Mee Moon, Leonard J. Foster, Robert C. Brunham

Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques Original Research Article Pages 2167-2174 Margherita Rosati, Candido Alicea, Viraj Kulkarni, Konstantin Virnik, Max Hockenbury, Niranjan Y. Sardesai, George N. Pavlakis, Antonio Valentin, Ira Berkower, Barbara K. Felber

Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination Original Research Article Pages 2175-2182 Stan L. Block, Shane Christensen, Bikash Verma, Fang Xie, Pavitra Keshavan, Peter M. Dull, Igor Smolenov

Vaccine coverage estimation using a computerized vaccination registry with potential underreporting and a seroprevalence study Original Research Article Pages 2183-2188 Lina Perez Breva, Javier Diez Domingo, Miguel Angel Martinez Beneito, Joan Puig Barbera

Immunogenicity and safety of AS03A-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 years Original Research Article Pages 2189-2195 Olivier Godeaux, Patricia Izurieta, Miguel Madariaga, Mamadou Drame, Ping Li, David W. Vaughn

Tabla de Contenidos. Volume 33, Issue 19, Pages 2197 - 2296, (27 April, 2015)

Editorial Board/Aims and Scope Pages IFC

Conference report

Vaccines, our shared responsibility Pages 2197-2202 Sonia Pagliusi, Rishabh Jain, Rajinder Kumar Suri, the DCVMN Executive Committee

Group

Brief report

Rabies vaccine preserved by vaporization is thermostable and immunogenic Pages 2203-2206 Todd G. Smith, Marina Siirin, Xianfu Wu, Cathleen A. Hanlon, Victor Bronshtein

Regular papers

The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype 2 Original Research Article Pages 2207-2212 Jana Seele, Lena-Maria Hillermann, Andreas Beineke, Maren Seitz, Ulrich von Pawel- Rammingen, Peter Valentin-Weigand, Christoph G. Baums

Cost–benefit of the introduction of new strategies for vaccination against pertussis in Spain: Cocooning and pregnant vaccination strategies Original Research Article Pages 2213-2220 Maria Isabel Fernandez-Cano, Lluis Armadans Gil, Magda Campins Marti

Meningococcal C conjugate age-dependant long-term loss of effectiveness Original Research Article Pages 2221-2227 M. Garrido-Estepa, O.G. Nunez, I. Leon-Gomez, R. Cano, R. Herruzo

Evaluation of a Salmonella Enteritidis vaccine and related ELISA for respective induction and assessment of acquired immunity to the vaccine and/or Echinacea purpurea in Awassi Ewes Original Research Article Pages 2228-2231 Elie K. Barbour, Chibli A. Abou Assi, Houssam Shaib, Shadi Hamadeh, Muhammad Murtada, Ghassan Mahmoud, Soonham Yaghmoor, Archana Iyer, Steve Harakeh, Taha Kumosani

Protective effect of a dewaxed whole-cell vaccine against Mycobacterium ulcerans infection in mice Original Research Article Pages 2232-2239 Mineo Watanabe, Hajime Nakamura, Ryutaro Nabekura, Noriko Shinoda, Eri Suzuki, Hajime Saito

A/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy Original Research Article Pages 2240-2247 Massimo Fabiani, Antonino Bella, Maria C. Rota, Elena Clagnan, Tolinda Gallo, Maurizio D’Amato, Patrizio Pezzotti, Lorenza Ferrara, Vittorio Demicheli, Domenico Martinelli, Rosa Prato, Caterina Rizzo

Development of a dual vaccine for prevention of Brucella abortus infection and Escherichia coli O157:H7 intestinal colonization Original Research Article Pages 2248-2253 Florencia Iannino, Claudia K. Herrmann, Mara S. Roset, Gabriel Briones

Evaluation of the protective efficacy of four novel identified membrane associated proteins of Streptococcus suis serotype 2 Original Research Article Pages 2254-2260 Yang Zhou, Yan Wang, Limei Deng, Chengkun Zheng, Fangyan Yuan, Huanchun Chen, Weicheng Bei, Jinquan Li

A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose Original Research Article Pages 2261-2266 Yoshimi Tsuda, Christopher J. Parkins, Patrizia Caposio, Friederike Feldmann, Sara Botto, Susan Ball, Ilhem Messaoudi, Luka Cicin-Sain, Heinz Feldmann, Michael A. Jarvis

Accounting for personal and professional choices for pandemic influenza vaccination amongst English healthcare workers Original Research Article Pages 2267-2272 Afrodita Marcu, Helena Rubinstein, Susan Michie, Lucy Yardley

A novel non-integrative single-cycle chimeric HIV lentivector DNA vaccine Original Research Article Pages 2273-2282 Maha Moussa, Geraldine Arrode-Bruses, Iliyan Manoylov, Alexander Malogolovkin, Dimitri Mompelat, Honorine Ishimwe, Amel Smaoune, Bilel Ouzrout, Jean Gagnon, Yahia Chebloune

Web-based intensive monitoring of adverse events following influenza vaccination in general practice Original Research Article Pages 2283-2288 Leontine van Balveren-Slingerland, Agnes Kant, Linda Harmark

Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cells Original Research Article Pages 2289-2296 Beata U. Orzechowska, Jolanta F. Kukowska-Latallo, Alexa D. Coulter, Zsuzsanna Szabo, Andrzej Gamian, Andrzej Myc

